Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Partow Kebriaei

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2013

English

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

Infusing CD19-Directed T Cells to Augment Disease Control in Patients Undergoing Autologous Hematopoietic Stem-Cell Transplantation for Advanced B-Lymphoid Malignancies

English

piggyBacTransposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage Malignancies

English

Progress in Novel Cellular Therapy Options for Chronic Lymphocytic Leukemia: The MD Anderson Perspective

Clinical Lymphoma, Myeloma and Leukemia

English

The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia

English

Feasibility of Allografting in Patients With Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin

Clinical Lymphoma, Myeloma and Leukemia

English

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia

English

Secondary Myelodysplastic Syndrome in a Patient With Philadelphia-Positive Acute Lymphoblastic Leukemia After Achieving a Major Molecular Response With hyperCVAD Plus Imatinib Mesylate

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Partow Kebriaei

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma

Infusing CD19-Directed T Cells to Augment Disease Control in Patients Undergoing Autologous Hematopoietic Stem-Cell Transplantation for Advanced B-Lymphoid Malignancies

piggyBacTransposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage Malignancies

Progress in Novel Cellular Therapy Options for Chronic Lymphocytic Leukemia: The MD Anderson Perspective

The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Feasibility of Allografting in Patients With Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

Secondary Myelodysplastic Syndrome in a Patient With Philadelphia-Positive Acute Lymphoblastic Leukemia After Achieving a Major Molecular Response With hyperCVAD Plus Imatinib Mesylate